Matthew Davids
MD, MMSc
Associate Professor of Medicine
👥Biography 个人简介
Matthew Davids is a CLL expert who has contributed to venetoclax development and understanding of BCL2 inhibitor resistance. His research on sequencing BTK inhibitors and venetoclax has established rational treatment algorithms. He has developed improved protocols for tumor lysis syndrome prevention in venetoclax-treated CLL patients.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Matthew Davids 的研究动态
Follow Matthew Davids's research updates
留下邮箱，当我们发布与 Matthew Davids（Dana-Farber Cancer Institute）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment